NR3C1 and prostate cancer: Interestingly, ETS factors have been shown to markedly enhance the chromatin occupancy of androgen receptor and reprogram its cistrome in prostate cancer cells [44], resembling the effect of hypoSUMOylation on GR cistrome in B-ALL cells.